As Hims Prepares for Peptides Launch, Wall Street Cautious on Prospects This Year

Sector Update: Healthcare

Hims & Hers Health Price Target Raised to $32.00/Share from $30.00 by B of a Securities

Hims & Hers Revenue Upside Tempered by Margin Concerns

Hims & Hers Stock (HIMS) Slides as GLP-1 Push Swallows Profits and Widens Q2 Loss

Hims & Hers Health Sees Mixed Q2 as Gross Margin, FCF Weigh, Morgan Stanley Says

Nvidia, Micron, DJT, SpaceX, Rocket Lab, Plug Power, Fermi, and More Stocks That Explain Today's Market

U.S. Stocks on the MOVE-Duke Energy, Sea, Cardinal Health

Hims & Hers Health, Inc. : Bofa Global Research Raises Price Objective to $32 from $30

Hims & Hers Health, Inc. : TD Cowen Raises Target Price to $30 from $25

Hims & Hers Shares Slide as Costly Weight-Loss Push Squeezes Margins

AST SpaceMobile, Intel, On, Hims, and More Stocks That Explain Today's Market

Hims & Hers Health, Inc. : Citigroup Cuts Target Price to $33 from $35

Morgan Stanley Adjusts PT on Hims & Hers Health to $28 From $21, Maintains Equalweight Rating

Dow Jones Top Company Headlines at 5 am ET: Intel Increases Size of Stock Offering to Raise $20 Billion | Samsung ...

Analysts Offer Insights on Healthcare Companies: Hims & Hers Health (HIMS), Lifestance Health Group (LFST) and DaVita (DVA)

Hims & Hers Health Falls After Bigger-than-Expected Q2 Loss

Hims & Hers Health Shares Down 7.3% Premarket After Co Posts Wider-than-Expected Q2 Loss